CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 97 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $5,000 | 0.0% | 197 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | -28.6% | 197 | -25.7% | 0.00% | – |
| Q4 2017 | $7,000 | +600.0% | 265 | +86.6% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 142 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | -50.0% | 142 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | -98.1% | 142 | -98.1% | 0.00% | -100.0% |
| Q1 2016 | $103,000 | -28.0% | 7,532 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $143,000 | -3.4% | 7,532 | -4.7% | 0.00% | 0.0% |
| Q3 2015 | $148,000 | +1245.5% | 7,905 | +1013.4% | 0.00% | – |
| Q2 2015 | $11,000 | – | 710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |